EE336 Budget Impact Analysis of Nefecon for the Treatment of Primary IgA Nephropathy in the United States
Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.581
https://www.valueinhealthjournal.com/article/S1098-3015(22)00782-3/fulltext
Title :
EE336 Budget Impact Analysis of Nefecon for the Treatment of Primary IgA Nephropathy in the United States
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00782-3&doi=10.1016/j.jval.2022.04.581
First page :
Section Title :
Open access? :
No
Section Order :
10523